107 related articles for article (PubMed ID: 1341239)
21. SCID mouse model of Epstein-Barr virus-induced lymphomagenesis of immunodeficient humans.
Purtilo DT; Falk K; Pirruccello SJ; Nakamine H; Kleveland K; Davis JR; Okano M; Taguchi Y; Sanger WG; Beisel KW
Int J Cancer; 1991 Feb; 47(4):510-7. PubMed ID: 1847355
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease.
Perera SM; Thomas JA; Burke M; Crawford DH
J Pathol; 1998 Feb; 184(2):177-84. PubMed ID: 9602709
[TBL] [Abstract][Full Text] [Related]
23. Identification of IgH gene rearrangement and immunophenotype in an animal model of Epstein-Barr virus-associated lymphomas.
Zhang Y; Peng X; Tang Y; Gan X; Wang C; Xie L; Xie X; Gan R; Wu Y
J Med Virol; 2016 Oct; 88(10):1804-13. PubMed ID: 26991077
[TBL] [Abstract][Full Text] [Related]
24. Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus.
Islas-Ohlmayer M; Padgett-Thomas A; Domiati-Saad R; Melkus MW; Cravens PD; Martin Mdel P; Netto G; Garcia JV
J Virol; 2004 Dec; 78(24):13891-900. PubMed ID: 15564497
[TBL] [Abstract][Full Text] [Related]
25. Hematopathologic features of Epstein-Barr virus-induced human B-lymphoproliferation in mice with severe combined immunodeficiency. A model of lymphoproliferative diseases in immunocompromised patients.
Nakamine H; Okano M; Taguchi Y; Pirruccello SJ; Davis JR; Beisel KW; Kleveland K; Sanger WG; Fordyce RR; Purtilo DT
Lab Invest; 1991 Oct; 65(4):389-99. PubMed ID: 1656139
[TBL] [Abstract][Full Text] [Related]
26. Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency.
Mosier DE; Gulizia RJ; Baird SM; Spector S; Spector D; Kipps TJ; Fox RI; Carson DA; Cooper N; Richman DD
Curr Top Microbiol Immunol; 1989; 152():195-9. PubMed ID: 2553338
[TBL] [Abstract][Full Text] [Related]
27. Posttransplant cutaneous lymphoma.
McGregor JM; Yu CC; Lu QL; Cotter FE; Levison DA; MacDonald DM
J Am Acad Dermatol; 1993 Oct; 29(4):549-54. PubMed ID: 8408789
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome.
Ohshima K; Suzumiya J; Sugihara M; Nagafuchi S; Ohga S; Kikuchi M
Pathol Int; 1998 Dec; 48(12):934-43. PubMed ID: 9952337
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.
Rowe M; Young LS; Crocker J; Stokes H; Henderson S; Rickinson AB
J Exp Med; 1991 Jan; 173(1):147-58. PubMed ID: 1845872
[TBL] [Abstract][Full Text] [Related]
30. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
31. Genotypic and phenotypic alterations in Epstein-Barr virus-associated lymphoma.
Ohshima K; Suzumiya J; Kanda M; Haraoka S; Kawasaki C; Shimazaki K; Kikuchi M
Histopathology; 1999 Dec; 35(6):539-50. PubMed ID: 10583578
[TBL] [Abstract][Full Text] [Related]
32. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation.
Cox KL; Lawrence-Miyasaki LS; Garcia-Kennedy R; Lennette ET; Martinez OM; Krams SM; Berquist WE; So SK; Esquivel CO
Transplantation; 1995 Feb; 59(4):524-9. PubMed ID: 7533344
[TBL] [Abstract][Full Text] [Related]
33. Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.
Bohlen H; Manzke O; Titzer S; Lorenzen J; Kube D; Engert A; Abken H; Wolf J; Diehl V; Tesch H
Cancer Res; 1997 May; 57(9):1704-9. PubMed ID: 9135012
[TBL] [Abstract][Full Text] [Related]
34. Effects of CD40 stimulation in the prevention of human EBV-lymphomagenesis.
Funakoshi S; Taub DD; Asai O; Hirano A; Ruscetti FW; Longo DL; Murphy WJ
Leuk Lymphoma; 1997 Jan; 24(3-4):187-99. PubMed ID: 9156649
[TBL] [Abstract][Full Text] [Related]
35. Lymphoproliferative disease after pediatric liver transplantation.
Morgan G; Superina RA
J Pediatr Surg; 1994 Sep; 29(9):1192-6. PubMed ID: 7807343
[TBL] [Abstract][Full Text] [Related]
36. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses.
Lacoste V; Judde JG; Bestett G; Cadranel J; Antoine M; Valensi F; Delabesse E; Macintyre E; Gessain A
Leuk Lymphoma; 2000 Jul; 38(3-4):401-9. PubMed ID: 10830748
[TBL] [Abstract][Full Text] [Related]
37. Gamma-globulin modulates growth of EBV-derived B-cell tumors in SCID mice reconstituted with human lymphocytes.
Abedi MR; Christensson B; al-Masud S; Hammarström L; Smith CI
Int J Cancer; 1993 Nov; 55(5):824-9. PubMed ID: 7503961
[TBL] [Abstract][Full Text] [Related]
38. Increased number of Epstein-Barr virus latently infected B-cells in T-cell non-Hodgkin's lymphoma tissues.
Hojo I; Takanashi M; Hirai K; Mori S
Arch Virol; 1995; 140(8):1419-26. PubMed ID: 7661694
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous development of a chromosomal translocation 5;14 in an Epstein-Barr-virus-associated B-cell lymphoma in a SCID mouse.
Glaser R; Theil KS; Bonneau RH; Sheridan JF; Vasquez M; Allen CM
Int J Cancer; 1993 Sep; 55(2):281-7. PubMed ID: 8396561
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus-induced human B-cell lymphoma arising in HuPBL-SCID chimeric mice: characterization and the role of CD40 stimulation in their treatment and prevention.
Funakoshi S; Beckwith M; Fanslow W; Longo DL; Murphy WJ
Pathobiology; 1995; 63(3):133-42. PubMed ID: 8821629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
